Scientific Information and Beliefs About Psychological Therapy

April 12, 2026 updated by: Golnaz Tabibnia, University of California, Irvine

The Effects of Science Education on Beliefs and Wellness

The success of psychological therapy can be impacted by patients' beliefs, such as their belief in their own ability to complete therapy and their belief that therapy will work. The goal of this clinical trial is to learn whether and when scientific information about distress and coping can affect beliefs about psychological therapy in adults who experience anxiety. This study will compare two different types of scientific information in a one-hour study. Participants will view educational videos for 30 minutes and complete surveys, including quiz questions about the videos and surveys about their beliefs about psychological therapy.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

262

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Irvine, California, United States, 92697
        • University of California

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Probable anxiety disorder based on the Overall Anxiety Severity and Impairment Scale (OASIS) score
  • Fluent in English
  • Willingness and ability to comply with the protocol
  • Age 18-80
  • The ability to enroll in the study through Prolific.com

Exclusion Criteria:

  • Having previously seen the study's videos

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neuro-Ed Group
neuroscience education
30 minutes of videos about the neuroscience of stress, fear, emotion-regulation, and therapy.
Other Names:
  • neuroscience education
  • Neuro-Ed
  • NeuroEd
Active Comparator: Psycho-Ed Group
psychological science education
30 minutes of videos about the psychological science of stress, fear, emotion-regulation, and therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment Self-Efficacy
Time Frame: Immediately before and immediately after watching the videos
Measured through self-report on selected items from a version of the validated Bergen Genetic Counseling Self-Efficacy Scale that was previously adapted for treatment self-efficacy in anxiety disorders. The items are rated on a scale of 1-10, with higher numbers indicating greater self-efficacy.
Immediately before and immediately after watching the videos
Treatment Expectancy
Time Frame: Immediately before and immediately after watching the videos
Measured through self-report on a subscale of the validated Credibility/Expectancy Questionnaire, assessing participants' expectation of treatment efficacy. Each item is rated on a scale of 1-9 or 0%-100%, with higher numbers indicating more optimistic expectancy.
Immediately before and immediately after watching the videos

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment Acceptability
Time Frame: Immediately after watching the videos
Participants will rate on a scale of 1-7 how useful, interesting, credible, and easy-to-understand they found the information in the videos. Greater numbers indicate greater acceptability.
Immediately after watching the videos

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Golnaz Tabibnia, PhD, University of California, Irvine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 21, 2025

Primary Completion (Actual)

October 9, 2025

Study Completion (Actual)

October 17, 2025

Study Registration Dates

First Submitted

January 23, 2025

First Submitted That Met QC Criteria

February 8, 2025

First Posted (Actual)

February 13, 2025

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 12, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified IPD that underlie results in a publication may be provided to qualified researchers with academic interest in science education and mental health. Approval of the request and execution of all applicable agreements may be prerequisites to the sharing of data with the requesting party.

IPD Sharing Time Frame

Data requests can be submitted starting 9 months after article publication, and the data will be made accessible for up to 5 years after study completion.

IPD Sharing Access Criteria

Researchers requesting data will first be asked to provide a research proposal. Pending approval of the proposal, they will then be asked to sign a data sharing agreement, which will include restrictions against attempting to identify study participants, on redistribution of the data to third parties, on use of the data for commercial purposes, as well as requirements to electronically secure the data while in use, to destroy the data after analyses are completed, for reporting responsibilities, and for proper acknowledgement of the data resource.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on neuro-education

Subscribe